Shares in Sanofi (NYSE:SNY) rose today after the company beat expectations on Wall Street with its 1st quarter results.
The French company posted profits of $5.7 billion on sales of $8.65 billion for the 3 months ended March 31, for bottom-line growth of 413.5% on sales growth of 11.2% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Sanofi Q1 earnings top estimates, diabetes sales fall appeared first on MassDevice.
from MassDevice http://ift.tt/2oQj1pc
Cap comentari:
Publica un comentari a l'entrada